|
|
Reference
|
|
  
|
American Diabetes Association (2014) Executive Summary: Standards of Medical Care in Diabetes 2014. Diabetes Care, 37(Supplement_1): S5-S13
|
|
|
Chakarova, N., Tankova, T., Atanassova, I., Dakovska, L. (2009) Serum lipid and hsCRP levels in prediabetes: Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Diabetes Research and Clinical Practice, 86(1): 56-60
|
|
|
Cominacini, L., Pasini, A.F., Garbin, U., Davoli, A., Tosetti, M.L., Campagnola, M., Rigoni, A., Pastorino, A.M., Lo, C.V., Sawamura, T. (2000) Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-κB through an Increased Production of Intracellular Reactive Oxygen Species. Journal of Biological Chemistry, 275(17): 12633-12638
|
|
|
Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., Tsukamoto, Y., Yoshiyama, M., Takeuchi, K., Yoshikawa, J., Becker, A.E. (2001) Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship with the Severity of Acute Coronary Syndromes. Circulation, 103(15): 1955-1960
|
|
2
|
Holvoet, P., Vanhaecke, J., Janssens, S., van de Werf, F., Collen, D. (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 98(15): 1487-94
|
|
|
Holvoet, P., Collen, D., van de Werf, F. (1999) Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA, 281: 1718-21
|
|
|
Huang, C.H., Chang, C.C., Huang, C.H., Kuo, C.L., Chen, C.P., Hsia, C.H., Chang, Y.C., Chen, H.P., Feng, C., Lin, L., Yang, P., Tsai, C., Lin, C., Liu, C. (2013) Using Oxidized Low-Density Lipoprotein Autoantibodies to Predict Restenosis after Balloon Angioplasty in Patients with Acute Myocardial Infarction. PLoS One, 8(10): e74726-e74726
|
|
|
Jaiswal, A., Tabassum, R., Podder, A., Ghosh, S., Tandon, N., Bharadwaj, D. (2012) Elevated level of C-reactive protein is associated with risk of prediabetes in Indians. Atherosclerosis, 222(2): 495-501
|
|
|
Khorrami, A., Ghanbarzadeh, S., Ziaee, M., Arami, S., Andalib, S., Maleki-Dizaji, N., Garjani, A. (2014) Effects of LDL and Oxidized LDL on Cardiac Function in Isoproterenol-induced Myocardial Infarction in Rat. Drug Research, Jan 17. 64(11): 576-583
|
|
1
|
Kim, K.H., Kim, W.H., Kang, W.Y., Hwang, S.H., Cho, S.C., Kim, W.H., Jeong, M.H. (2013) The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention. Korean Circulation Journal, 43(10): 664-664
|
|
|
Kopprasch, S., Pietzsch, J., Kuhlisch, E., Fuecker, K., Temelkova-Kurktschiev, T., Hanefeld, M., Kuhne, H., Julius, U., Graessler, J. (2002) In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance. Diabetes, 51(10): 3102-3106
|
|
9 
|
Korita, I., Bulo, A., Langlois, M., Blaton, V. (2013) Inflammation markers in patients with cardiovascular disease and metabolic syndrome. Journal of Medical Biochemistry, vol. 32, br. 3, str. 214-219
|
|
|
Levey, A.S., Coresh, J., Greene, T., Marsh, J., Stevens, L.A., Kusek, J.W., van Lente, F. (2007) Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values. Clinical Chemistry, 53(4): 766-772
|
|
|
Li, D., Mehta, J.L. (2005) Oxidized LDL: A critical factor in atherogenesis. Cardiovascular Research, 68(3): 353-354
|
|
|
Li, D., Mehta, J.L. (2000) Antisense to endothelial ox-LDL receptor LOX-1 inhibits ox-LDL-mediated upregulation of MCP-1 expression and monocyte adhesion to human coronary artery endothelial cells. Circulation, 101: 2889-95
|
|
|
Li, D., Mehta, J.L. (2000) Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: Evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(4): 1116-1122
|
|
|
Li, D., Liu, L., Chen, H., Sawamura, T., Ranganathan, S., Mehta, J.L. (2003) LOX-1 mediates oxidized LDL-induced expression of matrix metalloproteinases (MMPs) in human coronary artery endothelial cells. Circulation, 107(4): 612-617
|
|
|
Li, D., Williams, V., Liu, L., Chen, H., Sawamura, T., Romeo, F., Mehta, J.L. (2003) Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. Journal of the American College of Cardiology, 41(6): 1048-1055
|
|
|
Libby, P., Ridker, P.M., Hansson, G.K. (2009) Inflammation in atherosclerosis: From pathophysiology to practice. Journal of the American College of Cardiology, 54(23): 2129-2138
|
|
|
Mehta, J.L., Li, D.Y., Chen, H.J., Joseph, J., Romeo, F. (2001) Inhibition of LOX-1 by Statins May Relate to Upregulation of eNOS. Biochemical and Biophysical Research Communications, 289(4): 857-861
|
|
|
Mertens, A., Holvoet, P. (2001) Oxidized LDL and HDL: Antagonists in atherothrombosis. FASEB Journal, 15(12): 2073-2084
|
|
|
Nakhjavani, M., Khalilzadeh, O., Khajeali, L., Esteghamati, A., Morteza, A., Jamali, A., Dadkhahipour, S. (2010) Serum Oxidized-LDL is Associated with Diabetes Duration Independent of Maintaining Optimized Levels of LDL-Cholesterol. Lipids, 45(4): 321-327
|
|
|
Naruko, T., Ueda, M., Ehara, S., Itoh, A., Haze, K., Shirai, N., Ikura, Y., Ohsawa, M., Itabe, H., Kobayashi, Y., Yamagishi, H., Yoshiyama, M., Yoshikawa, J., Becker, A.E. (2006) Persistent High Levels of Plasma Oxidized Low-Density Lipoprotein After Acute Myocardial Infarction Predict Stent Restenosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(4): 877-883
|
|
|
Njajou, O.T., Kanaya, A.M., Holvoet, P., Connelly, S., Strotmeyer, E.S., Harris, T.B., Cummings, S.R., Hsueh, W. (2009) Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes/Metabolism Research and Reviews, 25(8): 733-739
|
|
1
|
Ortolani, P., Marzocchi, A., Marrozzini, C., Palmerini, T., Saia, F., Taglieri, N., Baldazzi, F., Silenzi, S., Bacchi-Reggiani, M.L., Guastaroba, P., Grilli, R., Branzi, A. (2008) Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European heart journal, 29(10): 1241-9
|
|
1
|
Ortolani, P., Marzocchi, A., Marrozzini, C., Palmerini, T., Saia, F., Taglieri, N., Baldazzi, F., Silenzi, S., Bacchi-Reggiani, M.L., Guastaroba, P., Grilli, R., Branzi, A. (2008) Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European heart journal, 29(10): 1241-9
|
|
|
Pfützner, A., Schöndorf, T., Hanefeld, M., Forst, T. (2010) High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment with Pioglitazone. Journal of Diabetes Science and Technology, 4(3): 706-716
|
|
|
Pfützner, A., Forst, T. (2006) High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus. Diabetes Technology & Therapeutics, 8(1): 28-36
|
|
|
Ren, S., Shatadal, S., Shen, G.X. (2000) Protein kinase C-β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells. American Journal of Physiology-Endocrinology and Metabolism, 278(4): E656-E662
|
|
17
|
Ridker, P.M., Rifai, N., Rose, L., Buring, J.E., Cook, N.R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347(20): 1557-65
|
|
|
Roubille, F., Cayla, G., Picot, M.C., Pradet, V., Massin, F., Gervasoni, R., et al. (2008) C-reactive protein (CRP) after revascularized STEM I: is CRP a prognostic factor?. Revue de Médecine Interne, 29: 868-74
|
|
|
Scirica, B.M., Morrow, D.A., Cannon, C.P., de Lemos, J.A., Murphy, S., Sabatine, M.S., Thrombolysis in Myocardial Infarction (TIM I) Study Group, et al. (2007) Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clinical Chemistry, 53: 1800-7
|
|
|
Sheehan, F.H., Braunwald, E., Canner, P., Dodge, H.T., Gore, J., van Natta, P., Passamani, E.R., Williams, D.O., Zaret, B. (1987) The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation, 75(4): 817-829
|
|
|
Shimada, K., Mokuno, H., Matsunaga, E., Miyazaki, T., Sumiyoshi, K., Kume, A., Miyauchi, K., Daida, H. (2004) Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care, 27(3): 843-844
|
|
|
Singh, U., Dasu, M.R., Yancey, P.G., Afify, A., Devaraj, S., Jialal, I. (2008) Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. Journal of Lipid Research, 49(5): 1015-1023
|
|
1
|
Steg, P.G., James, S.K., Atar, D., Badano, L.P., Blömstrom-Lundqvist, C., Borger, M.A., i dr. (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal, 33(20); 2569-619
|
|
|
Tomoda, H., Aoki, N. (2000) Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. American Heart Journal, 140(2): 324-328
|
|
|
Tsimikas, S., Bergmark, C., Beyer, R.W., Patel, R., Pattison, J., Miller, E., Juliano, J., Witztum, J.L. (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. Journal of the American College of Cardiology, 41(3): 360-370
|
|
1
|
Tsimikas, S., Lau, H.K., Han, K., Shortal, B., Miller, E.R., Segev, A., Curtiss, L.K., Witztum, J.L., Strauss, B.H. (2004) Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): Short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation, 109(25): 3164-70
|
|
|
Tsutsui, T., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Ohnishi, M., Kinoshita, M. (2002) Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. Journal of the American College of Cardiology, 39(6): 957-962
|
|
|
Zhang, Y., Wei, J.J., Wang, F., Chen, M., Zhang, M. (2012) Elevated Levels of Oxidized Low-Density Lipoprotein Correlate Positively with C-Reactive Protein in Patients with Acute Coronary Syndrome. Cell Biochemistry and Biophysics, 62(2): 365-372
|
|
|
Zhu, Y., Liao, H., Xie, X., Yuan, Y., Lee, T.S., Wang, N., et al. (2005) Oxidized LDL down regulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovascular Research, 68: 425-457
|
|
|
Zorn-Pauly, K., Schaffer, P., Pelzmann, B., Bernhart, E., Wei, G., Lang, P., Ledinski, G., Greilberger, J., Koidl, B., Jurgens, G. (2005) Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity-role of lipid hydroperoxides. Cardiovascular Research, 66(1): 74-83
|
|
|
Zuliani, G., Morieri, M.L., Volpato, S., Vigna, G.B., Tch, C.B., Maggio, M., Cherubini, A., Bandinelli, S., Guralnik, J.M., Ferrucci, L. (2013) Determinants and clinical significance of plasma oxidized LDLs in older individuals: A 9 years follow-up study. Atherosclerosis, 226(1): 201-207
|
|
|
|
|